126 related articles for article (PubMed ID: 7549160)
1. Bacteroides fragilis adheres to laminin significantly stronger than Bacteroides thetaiotaomicron and other species of the genus.
Eiring P; Manncke B; Gerbracht K; Werner H
Zentralbl Bakteriol; 1995 Apr; 282(3):279-86. PubMed ID: 7549160
[TBL] [Abstract][Full Text] [Related]
2. Lactoferrin and lactoferricin B reduce adhesion and biofilm formation in the intestinal symbionts Bacteroides fragilis and Bacteroides thetaiotaomicron.
de Sá Almeida JS; de Oliveira Marre AT; Teixeira FL; Boente RF; Domingues RMCP; de Paula GR; Lobo LA
Anaerobe; 2020 Aug; 64():102232. PubMed ID: 32634470
[TBL] [Abstract][Full Text] [Related]
3. Adherence of Bacteroides fragilis in vivo.
Onderdonk AB; Moon NE; Kasper DL; Bartlett JG
Infect Immun; 1978 Mar; 19(3):1083-7. PubMed ID: 640723
[TBL] [Abstract][Full Text] [Related]
4. The Bfp60 surface adhesin is an extracellular matrix and plasminogen protein interacting in Bacteroides fragilis.
Ferreira Ede O; Teixeira FL; Cordeiro F; Araujo Lobo L; Rocha ER; Smith JC; Domingues RM
Int J Med Microbiol; 2013 Dec; 303(8):492-7. PubMed ID: 23850366
[TBL] [Abstract][Full Text] [Related]
5. Adherence of Bacteroides fragilis group species.
Brook I; Myhal ML
Infect Immun; 1991 Feb; 59(2):742-4. PubMed ID: 1670934
[TBL] [Abstract][Full Text] [Related]
6. The Bacteroides fragilis cell envelope: quarterback, linebacker, coach-or all three?
Pumbwe L; Skilbeck CA; Wexler HM
Anaerobe; 2006; 12(5-6):211-20. PubMed ID: 17045496
[TBL] [Abstract][Full Text] [Related]
7. The interaction of Bacteroides fragilis with components of the human fibrinolytic system.
Ferreira Ede O; de Carvalho JB; Peixoto RJ; Lobo LA; Zingalli RB; Smith CJ; Rocha ER; Domingues RM
FEMS Immunol Med Microbiol; 2009 Jun; 56(1):48-55. PubMed ID: 19260960
[TBL] [Abstract][Full Text] [Related]
8. Aggregation by fragilis and non-fragilis Bacteroides strains in vitro.
Blake M; Rotstein OD; Llano M; Girotti MJ; Reid G
J Med Microbiol; 1989 Jan; 28(1):9-14. PubMed ID: 2536442
[TBL] [Abstract][Full Text] [Related]
9. The redox potential interferes with the expression of laminin binding molecules in Bacteroides fragilis.
Ferreira Ede O; Yates EA; Goldner M; Vommaro RC; Silva Filho FC; Petrópolis DB; Domingues RM
Mem Inst Oswaldo Cruz; 2008 Nov; 103(7):683-9. PubMed ID: 19057819
[TBL] [Abstract][Full Text] [Related]
10. Fibronectin and vitronectin binding of Bacteroides fragilis and eight other species of the genus.
Nagy E; Manncke B; Werner H
Zentralbl Bakteriol; 1994 Aug; 281(2):235-9. PubMed ID: 7532044
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic resistance and adhesion potential of Bacteroides fragilis clinical isolates from Cape Town, South Africa.
Galvão BP; Meggersee RL; Abratt VR
Anaerobe; 2011 Aug; 17(4):142-6. PubMed ID: 21530667
[TBL] [Abstract][Full Text] [Related]
12. Pathogenicity of the Bacteroides fragilis group.
Brook I
Ann Clin Lab Sci; 1989; 19(5):360-76. PubMed ID: 2679351
[TBL] [Abstract][Full Text] [Related]
13. A Bacteroides fragilis surface glycoprotein mediates the interaction between the bacterium and the extracellular matrix component laminin-1.
de O Ferreira E; Araújo Lobo L; Barreiros Petrópolis D; dos S Avelar KE; Ferreira MC; e Silva Filho FC; Domingues RM
Res Microbiol; 2006 Dec; 157(10):960-6. PubMed ID: 17125972
[TBL] [Abstract][Full Text] [Related]
14. Recovery of Bacteroides fragilis group from clinical specimens following antimicrobial therapy.
Brook I; Frazier EH
Can J Microbiol; 1992 Mar; 38(3):226-9. PubMed ID: 1393825
[TBL] [Abstract][Full Text] [Related]
15. Detection of Bacteroides fragilis, Bacteroides thetaiotaomicron, and Bacteroides ovatus in clinical specimens by immunofluorescence with a monoclonal antibody to B. fragilis lipopolysaccharide.
Viljanen MK; Linko L; Lehtonen OP
J Clin Microbiol; 1988 Mar; 26(3):448-52. PubMed ID: 3281973
[TBL] [Abstract][Full Text] [Related]
16. [The effect of oxygen on endotoxin production in bacteria of the Bacteroides fragilis group isolated from patients with colorectal carcinoma].
Chmelař D; Hájek M; Janečková J; Vobejdová J; Martineková P; Kašíková A
Epidemiol Mikrobiol Imunol; 2016; 65(2):129-35. PubMed ID: 27467330
[TBL] [Abstract][Full Text] [Related]
17. Capsular and 'O' serotype determinants of bacteroides fragilis.
Tabaqchali S; Fiddian PA; El-Hag K; Kasper DL
Infection; 1982; 10(6):333-7. PubMed ID: 6185437
[TBL] [Abstract][Full Text] [Related]
18. [Bacteroides and appendicitis (author's transl)].
Werner H; Kunstek-Santos H; Schockemöhle C; Gündürewa M
Pathol Microbiol (Basel); 1975; 42(2):110-8. PubMed ID: 1178229
[TBL] [Abstract][Full Text] [Related]
19. In vitro adhesiveness of Bacteroides fragilis group in relation to encapsulation.
Beena VK; Shivananda PG
Indian J Med Res; 1997 Jun; 105():258-61. PubMed ID: 9277037
[TBL] [Abstract][Full Text] [Related]
20. Antibiotic susceptibility profiles of Bacteroides fragilis and Bacteroides thetaiotaomicron in Japan from 1990 to 1992.
Tanaka-Bandoh K; Kato N; Watanabe K; Ueno K
Clin Infect Dis; 1995 Jun; 20 Suppl 2():S352-5. PubMed ID: 7548596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
